
Rec-Biotechnology
Dedicated to the R&D, production and commercialization of innovative vaccines, leveraging its core technology platforms.
Market cap
$461m
Enterprise value
$519m
Share price
HKD7.74 2179.HK
Authorizing premium user...
Dedicated to the R&D, production and commercialization of innovative vaccines, leveraging its core technology platforms.